The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999-2019).
Primary immunodeficiencies
patient registry
Journal
Journal of clinical immunology
ISSN: 1573-2592
Titre abrégé: J Clin Immunol
Pays: Netherlands
ID NLM: 8102137
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
02
04
2020
accepted:
06
08
2020
pubmed:
18
8
2020
medline:
9
10
2021
entrez:
18
8
2020
Statut:
ppublish
Résumé
Primary immunodeficiencies (PIDs) are heterogeneous disorders, characterized by variable clinical and immunological features. National PID registries offer useful insights on the epidemiology, diagnosis, and natural history of these disorders. In 1999, the Italian network for primary immunodeficiencies (IPINet) was established. We report on data collected from the IPINet registry after 20 years of activity. A total of 3352 pediatric and adult patients affected with PIDs are registered in the database. In Italy, a regional distribution trend of PID diagnosis was observed. Based on the updated IUIS classification of 2019, PID distribution in Italy showed that predominantly antibody deficiencies account for the majority of cases (63%), followed by combined immunodeficiencies with associated or syndromic features (22.5%). The overall age at diagnosis was younger for male patients. The minimal prevalence of PIDs in Italy resulted in 5.1 per 100.000 habitants. Mortality was similar to other European registries (4.2%). Immunoglobulin replacement treatment was prescribed to less than one third of the patient cohort. Collectively, this is the first comprehensive description of the PID epidemiology in Italy.
Identifiants
pubmed: 32803625
doi: 10.1007/s10875-020-00844-0
pii: 10.1007/s10875-020-00844-0
pmc: PMC7505879
doi:
Types de publication
Historical Article
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1026-1037Références
J Clin Immunol. 2007 Sep;27(5):517-24
pubmed: 17588141
Front Immunol. 2019 Jul 19;10:1272
pubmed: 31379802
J Clin Immunol. 1997 Jul;17(4):333-9
pubmed: 9258772
Isr Med Assoc J. 2002 Nov;4(11 Suppl):868-71
pubmed: 12455164
Clin Exp Immunol. 2018 Jun;192(3):284-291
pubmed: 29878323
Front Immunol. 2019 Jul 24;10:1754
pubmed: 31396239
J Clin Immunol. 2015 Nov;35(8):745-53
pubmed: 26464197
J Clin Immunol. 2020 Jan;40(1):66-81
pubmed: 32048120
Adv Exp Med Biol. 2017;1031:3-21
pubmed: 29214563
J Clin Immunol. 2016 Nov;36(8):764-773
pubmed: 27582173
Pediatrics. 2019 Feb;143(2):
pubmed: 30683812
Ann Ist Super Sanita. 2019 Jul-Sep;55(3):296-304
pubmed: 31553326
Clin Exp Immunol. 2015 Oct;182(1):45-50
pubmed: 26031847
J Clin Immunol. 2020 Jan;40(1):24-64
pubmed: 31953710
J Clin Immunol. 2000 Nov;20(6):477-85
pubmed: 11202238
J Clin Immunol. 2015 Jan;35(1):75-9
pubmed: 25315263
Clin Immunol. 2010 May;135(2):264-72
pubmed: 20399414
J Clin Immunol. 2005 Jan;25(1):73-7
pubmed: 15742160
J Clin Immunol. 2014 May;34(4):459-68
pubmed: 24619622
Bone Marrow Transplant. 2008 Jun;41 Suppl 2:S35-8
pubmed: 18545242
Clin Immunol. 2015 Feb;156(2):154-62
pubmed: 25451158